Acute and Chronic Abnormal Uterine Bleeding Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: AF487D24D148EN
Market Monitor Global

Abstracts

Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy.

This report contains market size and forecasts of Acute and Chronic Abnormal Uterine Bleeding in Global, including the following market information:

Global Acute and Chronic Abnormal Uterine Bleeding Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Acute and Chronic Abnormal Uterine Bleeding market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hormonal Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acute and Chronic Abnormal Uterine Bleeding include BD, Cook Medical, Teleflex, Utah Medical Products, Kentec Medical, Glenveigh Medical and Clinical Innovations, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute and Chronic Abnormal Uterine Bleeding companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute and Chronic Abnormal Uterine Bleeding Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acute and Chronic Abnormal Uterine Bleeding Market Segment Percentages, by Type, 2021 (%)

• Hormonal Treatment
• Non-hormonal Treatment

Global Acute and Chronic Abnormal Uterine Bleeding Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Acute and Chronic Abnormal Uterine Bleeding Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Acute and Chronic Abnormal Uterine Bleeding Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acute and Chronic Abnormal Uterine Bleeding Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Acute and Chronic Abnormal Uterine Bleeding revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Acute and Chronic Abnormal Uterine Bleeding revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BD
• Cook Medical
• Teleflex
• Utah Medical Products
• Kentec Medical
• Glenveigh Medical
• Clinical Innovations

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Acute and Chronic Abnormal Uterine Bleeding Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Acute and Chronic Abnormal Uterine Bleeding Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACUTE AND CHRONIC ABNORMAL UTERINE BLEEDING OVERALL MARKET SIZE

2.1 Global Acute and Chronic Abnormal Uterine Bleeding Market Size: 2021 VS 2028
2.2 Global Acute and Chronic Abnormal Uterine Bleeding Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Acute and Chronic Abnormal Uterine Bleeding Players in Global Market
3.2 Top Global Acute and Chronic Abnormal Uterine Bleeding Companies Ranked by Revenue
3.3 Global Acute and Chronic Abnormal Uterine Bleeding Revenue by Companies
3.4 Top 3 and Top 5 Acute and Chronic Abnormal Uterine Bleeding Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute and Chronic Abnormal Uterine Bleeding Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute and Chronic Abnormal Uterine Bleeding Players in Global Market
  3.6.1 List of Global Tier 1 Acute and Chronic Abnormal Uterine Bleeding Companies
  3.6.2 List of Global Tier 2 and Tier 3 Acute and Chronic Abnormal Uterine Bleeding Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Acute and Chronic Abnormal Uterine Bleeding Market Size Markets, 2021 & 2028
  4.1.2 Hormonal Treatment
  4.1.3 Non-hormonal Treatment
4.2 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue & Forecasts
  4.2.1 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2022
  4.2.2 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2023-2028
  4.2.3 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Other
5.2 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue & Forecasts
  5.2.1 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2022
  5.2.2 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2023-2028
  5.2.3 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Market Size, 2021 & 2028
6.2 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue & Forecasts
  6.2.1 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2022
  6.2.2 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2023-2028
  6.2.3 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
  6.3.2 US Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.3.3 Canada Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.3.4 Mexico Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
  6.4.2 Germany Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.4.3 France Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.4.4 U.K. Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.4.5 Italy Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.4.6 Russia Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.4.7 Nordic Countries Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.4.8 Benelux Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
  6.5.2 China Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.5.3 Japan Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.5.4 South Korea Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.5.5 Southeast Asia Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.5.6 India Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
  6.6.2 Brazil Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.6.3 Argentina Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
  6.7.2 Turkey Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.7.3 Israel Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.7.4 Saudi Arabia Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
  6.7.5 UAE Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BD
  7.1.1 BD Corporate Summary
  7.1.2 BD Business Overview
  7.1.3 BD Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.1.4 BD Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.1.5 BD Key News
7.2 Cook Medical
  7.2.1 Cook Medical Corporate Summary
  7.2.2 Cook Medical Business Overview
  7.2.3 Cook Medical Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.2.4 Cook Medical Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.2.5 Cook Medical Key News
7.3 Teleflex
  7.3.1 Teleflex Corporate Summary
  7.3.2 Teleflex Business Overview
  7.3.3 Teleflex Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.3.4 Teleflex Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.3.5 Teleflex Key News
7.4 Utah Medical Products
  7.4.1 Utah Medical Products Corporate Summary
  7.4.2 Utah Medical Products Business Overview
  7.4.3 Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.4.4 Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.4.5 Utah Medical Products Key News
7.5 Kentec Medical
  7.5.1 Kentec Medical Corporate Summary
  7.5.2 Kentec Medical Business Overview
  7.5.3 Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.5.4 Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.5.5 Kentec Medical Key News
7.6 Glenveigh Medical
  7.6.1 Glenveigh Medical Corporate Summary
  7.6.2 Glenveigh Medical Business Overview
  7.6.3 Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.6.4 Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.6.5 Glenveigh Medical Key News
7.7 Clinical Innovations
  7.7.1 Clinical Innovations Corporate Summary
  7.7.2 Clinical Innovations Business Overview
  7.7.3 Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
  7.7.4 Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
  7.7.5 Clinical Innovations Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acute and Chronic Abnormal Uterine Bleeding Market Opportunities & Trends in Global Market
Table 2. Acute and Chronic Abnormal Uterine Bleeding Market Drivers in Global Market
Table 3. Acute and Chronic Abnormal Uterine Bleeding Market Restraints in Global Market
Table 4. Key Players of Acute and Chronic Abnormal Uterine Bleeding in Global Market
Table 5. Top Acute and Chronic Abnormal Uterine Bleeding Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acute and Chronic Abnormal Uterine Bleeding Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acute and Chronic Abnormal Uterine Bleeding Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acute and Chronic Abnormal Uterine Bleeding Product Type
Table 9. List of Global Tier 1 Acute and Chronic Abnormal Uterine Bleeding Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute and Chronic Abnormal Uterine Bleeding Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acute and Chronic Abnormal Uterine Bleeding Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acute and Chronic Abnormal Uterine Bleeding Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acute and Chronic Abnormal Uterine Bleeding Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acute and Chronic Abnormal Uterine Bleeding Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2023-2028
Table 30. BD Corporate Summary
Table 31. BD Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 32. BD Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)
Table 33. Cook Medical Corporate Summary
Table 34. Cook Medical Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 35. Cook Medical Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)
Table 36. Teleflex Corporate Summary
Table 37. Teleflex Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 38. Teleflex Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)
Table 39. Utah Medical Products Corporate Summary
Table 40. Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 41. Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)
Table 42. Kentec Medical Corporate Summary
Table 43. Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 44. Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)
Table 45. Glenveigh Medical Corporate Summary
Table 46. Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 47. Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)
Table 48. Clinical Innovations Corporate Summary
Table 49. Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Product Offerings
Table 50. Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Acute and Chronic Abnormal Uterine Bleeding Segment by Type in 2021
Figure 2. Acute and Chronic Abnormal Uterine Bleeding Segment by Application in 2021
Figure 3. Global Acute and Chronic Abnormal Uterine Bleeding Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acute and Chronic Abnormal Uterine Bleeding Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute and Chronic Abnormal Uterine Bleeding Revenue in 2021
Figure 8. By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 12. US Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 16. Germany Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 17. France Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 24. China Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 28. India Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 30. Brazil Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
Figure 33. Turkey Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acute and Chronic Abnormal Uterine Bleeding Revenue, (US$, Mn), 2017-2028
Figure 37. BD Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cook Medical Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teleflex Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Revenue Year Over Year Growth (US$, Mn) & (2017-2022)